Henk Timmerman

Pharmacochemistry Vrije Universiteit Amsterdam, Amsterdam, Netherlands 
"Henk Timmerman"
Mean distance: 13.48


Sign in to add mentor
Wybe Th. Nauta grad student 1967 Free University of Amsterdam
 (2-alkyl-1-[ortho-alkyl-phenyl] cyclohexanols, synthesis, conformation and some pharmacological investigations)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kooistra AJ, de Graaf C, Timmerman H. (2014) The receptor concept in 3D: from hypothesis and metaphor to GPCR-ligand structures. Neurochemical Research. 39: 1850-61
Malan SF, van Marle A, Menge WM, et al. (2012) Corrigendum to “Fluorescent ligands for the histamine H2 receptor: Synthesis and preliminary characterization” [Bioorg. Med. Chem. 12 (2004) 6495–6503 Bioorganic & Medicinal Chemistry. 20: 6003
Wijtmans M, Denonne F, Célanire S, et al. (2010) Histamine H3 receptor ligands with a 3-cyclobutoxy motif: A novel and versatile constraint of the classical 3-propoxy linker Medchemcomm. 1: 39-44
van Muijlwijk-Koezen JE, Timmerman H, van der Sluis RP, et al. (2010) ChemInform Abstract: Synthesis and Use of FSCPX, an Irreversible Adenosine A1 Antagonist, as a “Receptor Knock-Down” Tool. Cheminform. 32: no-no
Célanire S, Wijtmans M, Christophe B, et al. (2009) Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists. Chemmedchem. 4: 1063-8
Wijtmans M, Celanire S, Snip E, et al. (2008) 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists. Journal of Medicinal Chemistry. 51: 2944-53
Bakker RA, Jongejan A, Sansuk K, et al. (2008) Constitutively active mutants of the histamine H1 receptor suggest a conserved hydrophobic asparagine-cage that constrains the activation of class A G protein-coupled receptors. Molecular Pharmacology. 73: 94-103
Storelli S, Verzijl D, Al-Badie J, et al. (2007) Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists. Archiv Der Pharmazie. 340: 281-91
Bakker RA, Nicholas MW, Smith TT, et al. (2007) In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonists. The Journal of Pharmacology and Experimental Therapeutics. 322: 172-9
Dai H, Fu Q, Shen Y, et al. (2007) The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons. European Journal of Pharmacology. 563: 117-23
See more...